139 related articles for article (PubMed ID: 2454600)
21. A phase I study of human lymphoblastoid interferon in patients with hematological malignancies.
Rohatiner A; Balkwill F; Malpas JS; Lister TA
Haematol Blood Transfus; 1981; 26():63-7. PubMed ID: 6172324
[No Abstract] [Full Text] [Related]
22. Interferon's track record: good in hairy-cell leukemia, fair in other hematologic cancers, poor in solid tumors.
Merz B
JAMA; 1986 Sep; 256(10):1242-4. PubMed ID: 2427752
[No Abstract] [Full Text] [Related]
23. Lymphoproliferative disorder of the central nervous system in AIDS.
Song SK; Schwartz IS; Breakstone BA
Mt Sinai J Med; 1986 Dec; 53(8):686-9. PubMed ID: 3492672
[No Abstract] [Full Text] [Related]
24. AIDS--clinical synopsis.
Wolff K; Stingl G
Curr Probl Dermatol; 1989; 18():218-28. PubMed ID: 2663365
[No Abstract] [Full Text] [Related]
25. Lymphoproliferative disorders and other tumors complicating immunodeficiencies.
Filipovich AH; Mathur A; Kamat D; Kersey JH; Shapiro RS
Immunodeficiency; 1994; 5(2):91-112. PubMed ID: 8032367
[TBL] [Abstract][Full Text] [Related]
26. [Effect of interferon therapy on the function of the peripheral blood granulocytes in patients with malignant diseases].
Seidel J; von Wussow P; Naucke C; Stangel W; Mirkhani J; Behrmann M
Beitr Infusionther Klin Ernahr; 1987; 18():272-5. PubMed ID: 2449890
[No Abstract] [Full Text] [Related]
27. Clinical testing of human interferon in infectious diseases.
Merigan TC
In Vitro Monogr; 1974; (3):57-62. PubMed ID: 4377883
[No Abstract] [Full Text] [Related]
28. Current clinical status of interferon and management of cancer in man.
Horoszewicz JS; Mirand EA
Prog Clin Biol Res; 1983; 132E():315-25. PubMed ID: 6196789
[No Abstract] [Full Text] [Related]
29. [Pharmacological study of human leukocytic interferon].
Scherbakova EG; Eĭdelshteĭn SI; Furer NM
Antibiotiki; 1973 Mar; 18(3):256-9. PubMed ID: 4357951
[No Abstract] [Full Text] [Related]
30. Interferon: a model for future biologicals.
Oldham RK
Interferon; 1985; 6():127-43. PubMed ID: 2410369
[No Abstract] [Full Text] [Related]
31. Interferon may enhance the activity of interleukin-2.
Oncology (Williston Park); 1988 Jul; 2(7):11. PubMed ID: 2484280
[No Abstract] [Full Text] [Related]
32. Further evidence of neurological sequelae associated with interferon therapy in the paediatric population.
Murray DM; Hensey OJ; O'Dwyer TP; King MD
Eur J Paediatr Neurol; 2000; 4(6):295-6. PubMed ID: 11277372
[No Abstract] [Full Text] [Related]
33. Pharmacokinetic and pharmacological aspects of interferon therapy in man.
Billiau A
Acta Microbiol Acad Sci Hung; 1981; 28(3):257-62. PubMed ID: 6171139
[No Abstract] [Full Text] [Related]
34. Advances in interferon.
Finter NB
Practitioner; 1982 Oct; 226(1372):1729-34. PubMed ID: 6184707
[No Abstract] [Full Text] [Related]
35. Interferon therapy.
World Health Organ Tech Rep Ser; 1982; 676():1-28. PubMed ID: 6178225
[No Abstract] [Full Text] [Related]
36. Clinical study of recombinant DNA-produced leukocyte interferon (clone A) in a intermittent schedule in cancer patients.
Quesada JR; Gutterman JU
J Natl Cancer Inst; 1983 Jun; 70(6):1041-6. PubMed ID: 6190033
[TBL] [Abstract][Full Text] [Related]
37. Interferon: no magic bullet against cancer.
Sun M
Science; 1981 Apr; 212(4491):141-2. PubMed ID: 6163213
[No Abstract] [Full Text] [Related]
38. The interferons--Part 1.
Freeman PR
Am Pharm; 1994 May; NS34(5):24-6. PubMed ID: 7518644
[No Abstract] [Full Text] [Related]
39. Interferon.
Katrak M
Nurs Times; 1983 Jul 6-12; 79(27):53-4. PubMed ID: 6194515
[No Abstract] [Full Text] [Related]
40. [Interferon].
Tigaud JM; Duarte A; Psyche S; Droz JP
Rev Infirm; 1991 Dec; 41(19):32-3. PubMed ID: 1722901
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
